Elevation Wealth Partners’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-15
Closed -$53 486
2024
Q2
$53 Hold
15
﹤0.01% 492
2024
Q1
$43 Hold
15
﹤0.01% 460
2023
Q4
$39 Buy
+15
New +$43 ﹤0.01% 426

Other funds holding SRTA

Elevation Wealth Partners's SRTA Position: Q3 2024 in Review

Elevation Wealth Partners sold out of Strata Critical Medical Inc (SRTA) in Q3 2024, closing a stake of 15 shares — an estimated $53 sold.

Elevation Wealth Partners first reported a position in SRTA in Q4 2023 and held it in 3 quarters. The position peaked at $53 in Q2 2024. 120 funds tracked by Wall St. Rank hold SRTA as of Q3 2024.

  • Elevation Wealth Partners reported no remaining Strata Critical Medical Inc position as of Q3 2024 after selling out during the quarter.
  • Elevation Wealth Partners sold 15 Strata Critical Medical Inc shares in Q3 2024, an estimated $53.
  • Elevation Wealth Partners first reported a position in Strata Critical Medical Inc in Q4 2023 and held it in 3 quarters.
  • Elevation Wealth Partners's Strata Critical Medical Inc position peaked at $53 in Q2 2024.
  • 120 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q3 2024.

Based on Elevation Wealth Partners's 13F filing for Q3 2024, filed 4 Oct 2024.